Literature DB >> 19575418

Investigation of multifocal choroiditis with panuveitis by three-dimensional high-penetration optical coherence tomography.

Yoshiaki Yasuno1, Fumiki Okamoto, Keisuke Kawana, Toyohiko Yatagai, Tetsuro Oshika.   

Abstract

A single case of multifocal choroiditis with panuveitis (MFCPU) was investigated by a three-dimensional (3-D) high-penetration optical coherence tomography. The HP-OCT is based on a swept-source OCT technology, uses a probe beam with a center wavelength of 1060 nm, and possesses a depth resolution of 10.4 micromin tissue. Two eyes of an MFCPU patient were involved in this study. The eyes were also examined by color fundus photograph, fluorescein angiography (FA), and indocyanine green angiography (ICGA). Findings in these four modalities are comparatively discussed. The OCT scans revealed the following characteristic properties of the lesion sites. Thinning of the retina, destructuring of the retinal layers, and disappearance of the junction of the inner and outer segments of the photoreceptor (IS/OS). Due to the high penetration of this OCT system, the following characteristic properties of the lesions were also observed: localized thinning of the choroid, occlusion of the choroidal vessels, and localized hyper-reflectivity that may represent hyper-pigmentation of the choroid.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19575418     DOI: 10.1002/jbio.200910017

Source DB:  PubMed          Journal:  J Biophotonics        ISSN: 1864-063X            Impact factor:   3.207


  9 in total

Review 1.  Optical coherence tomography imaging in uveitis.

Authors:  Sumru Onal; Ilknur Tugal-Tutkun; Piergiorgio Neri; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2013-07-09       Impact factor: 2.031

2.  Multifunctional imaging of human retina and choroid with 1050-nm spectral domain optical coherence tomography at 92-kHz line scan rate.

Authors:  Ruikang K Wang; Lin An
Journal:  J Biomed Opt       Date:  2011-05       Impact factor: 3.170

Review 3.  Choroidal imaging using spectral-domain optical coherence tomography.

Authors:  Caio V Regatieri; Lauren Branchini; James G Fujimoto; Jay S Duker
Journal:  Retina       Date:  2012-05       Impact factor: 4.256

4.  Choroidal volume variations with age, axial length, and sex in healthy subjects: a three-dimensional analysis.

Authors:  Giulio Barteselli; Jay Chhablani; Sharif El-Emam; Haiyan Wang; Janne Chuang; Igor Kozak; Lingyun Cheng; Dirk-Uwe Bartsch; William R Freeman
Journal:  Ophthalmology       Date:  2012-08-24       Impact factor: 12.079

5.  A case of overlapping choriocapillaritis syndromes: multimodal imaging appraisal.

Authors:  Tatiana Kuznetcova; Bruno Jeannin; Carl P Herbort
Journal:  J Ophthalmic Vis Res       Date:  2012-01

6.  Importance of proper diagnosis for management: multifocal choroiditis mimicking ocular histoplasmosis syndrome.

Authors:  Elham Hatef; Peykan Turkcuoglu; Mohamed Ibrahim; Yasir Sepah; Matthew Shulman; Jangwon Heo; Jeong Hee Lee; Roomasa Channa; Afsheen Khwaja; Zubir Rentiya; Syed Mahmood Shah; Diana V Do; Quan Dong Nguyen
Journal:  J Ophthalmic Inflamm Infect       Date:  2011-03-16

7.  Relationships of Rheumatoid Factor with Thickness of Retina and Choroid in Subjects without Ocular Symptoms Using Swept-Source Optical Coherence Tomography.

Authors:  Qingjian Li; Yiwen Qian; Sennan Xu; Minjie Zhang; Xu Liang; Xin Che; Jing Jiang; Zuguo Liu; Yu Zhang; Yan Liu; Zhiliang Wang
Journal:  J Immunol Res       Date:  2021-03-24       Impact factor: 4.818

8.  Retinal and Choroidal Thickness in relation to C-Reactive Protein on Swept-Source Optical Coherence Tomography.

Authors:  Dawei Fang; Qingjian Li; Ke Yan; Sennan Xu; Jing Jiang; Xin Che; Yu Zhang; Yiwen Qian; Zhiliang Wang
Journal:  J Immunol Res       Date:  2021-01-25       Impact factor: 4.818

9.  Choroidal assessment in idiopathic panuveitis using optical coherence tomography.

Authors:  Michael Karampelas; Dawn A Sim; Pearse A Keane; Javier Zarranz-Ventura; Praveen J Patel; Adnan Tufail; Mark Westcott; Richard Lee; Carlos E Pavesio
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-03-28       Impact factor: 3.117

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.